European Pharmaceutical Review

SEPTEMBER 14, 2023

Once operational in early 2025, the partnership will reduce emissions by an estimated 20,000 tonnes CO 2 equivalent (CO 2 e). Alongside this move, AstraZeneca’s investment in major energy efficiencies in its operations, brings the total of its financial commitment to net zero, to £100 million.

Manufacturing 111

Manufacturing Medicine Pharmaceutical manufacturing Pharma 111

European Pharmaceutical Review

SEPTEMBER 26, 2022

AbbVie , an international R&D biopharmaceutical enterprise has celebrated its 20th anniversary by investing in extensive renovations at its manufacturing site in Cork, Ireland. The €60 million expansion will open 70 new jobs in sterile manufacturing, quality control and engineering in 2025.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Biopharma Engineering 98

Clarivate

AUGUST 20, 2024

In 2025, CMS will select another 15 Part D drugs for negotiations that will take effect in 2027. That compares to the $240.4 billion in spending across all Part D drugs that year (2022) and the $43.6 billion spent on all Part B drugs that same year.

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52